Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), announced significant progress in the continued expansion of its global clinical manufacturing network. With the ongoing scale-up of its…
CareQuest Institute Appoints An Nguyen, DDS, MPH, to Serve as Chief Clinical Officer CareQuest Institute for Oral Health has announced the appointment of An Nguyen, DDS, MPH, as its new Chief Clinical Officer, marking a significant leadership addition as the…
Clarametyx Biosciences Enhances Leadership Team to Advance Clinical Development Initiatives Clarametyx Biosciences, Inc., a clinical-stage biotechnology company focused on developing immune-enabling therapies and vaccines to combat biofilm-driven chronic respiratory diseases, has announced key leadership promotions within its executive team. These…
Real Time Medical Systems to Showcase How Live Data Enhances Clinical Standards and Survey Readiness at PALTC26 Real Time Medical Systems, widely recognized as a leading provider of post-acute care analytics and a KLAS-rated, HITRUST-certified solution, has announced its expanded…
Angelalign Technology Reports 2025 Results, Highlighting Clinical Excellence as a Key Driver of Global Expansion Angelalign Technology Inc. (6699.HK) has announced its financial results for the fiscal year 2025, reporting strong performance across both its domestic China market and international…
Imperative Care Launches CLEAR-IT Clinical Study to Advance Standards in Peripheral Thromboembolism Treatment Imperative Care Inc has announced a significant milestone in its efforts to advance treatment options for patients with thromboembolic diseases, marking the enrollment of the first patient…
BioNTech presents new ELCC 2026 data underscoring the strength and differentiation of its late-stage lung cancer pipeline BioNTech has announced that it will showcase new clinical data from its expanding lung cancer pipeline at the European Lung Cancer Congress 2026,…
Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies Seeking Efficient Way to Enter European Markets Veristat, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced expanded regulatory and clinical trial services to…
TIXiMED Reports Promising Preclinical Results for Oral TIX100 in Preventing Weight Regain After GLP-1 Therapy TIXiMED a clinical-stage pharmaceutical company focused on developing innovative treatments for diabetes and metabolic diseases, has announced encouraging new preclinical findings for its investigational oral…
Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus Mirum Pharmaceuticals, Inc. a leading rare disease company, today announced completion of enrollment in the Phase 3 AZURE-1 study and completion of screening in the Phase…
Parabilis Medicines Reports Early Clinical Evidence that Zolucatetide Reduces Polyp Burden in a Patient with Familial Adenomatous Polyposis Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer using its Helicon™ peptide platform to…
ImmunoScape Announces Memorandum of Understanding for Clinical Trial with Premier U.S. Cancer Center ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures and EDBI that is developing next-generation TCR-based cancer immunotherapies, today announced the execution of a Memorandum of…